A robust prognostic signature for hormone-positive node-negative breast cancer

BACKGROUND: Systemic chemotherapy in the adjuvant setting can cure breast cancer in some patients that would otherwise recur with incurable, metastatic disease. However, since only a fraction of patients would have recurrence after surgery alone, the challenge is to stratify high-risk patients (who...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffith, Obi L, Pepin, François, Enache, Oana M, Heiser, Laura M, Collisson, Eric A, Spellman, Paul T, Gray, Joe W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961800/
https://www.ncbi.nlm.nih.gov/pubmed/24112773
http://dx.doi.org/10.1186/gm496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961800/
https://www.ncbi.nlm.nih.gov/pubmed/24112773
http://dx.doi.org/10.1186/gm496

Ejemplares similares